TrialCancer immunology, immunotherapy : CII2026

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial.

Hyunjae Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.